Description:

ANHL01P1: Institutional Pathology Form [reload] NCT00057811 Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BA57175F-244D-0585-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BA57175F-244D-0585-E034-0003BA12F5E7

Keywords:
Versions (4) ▾
  1. 8/27/12
  2. 1/9/15
  3. 1/9/15
  4. 6/27/15
Uploaded on:

June 27, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

ANHL01P1: Institutional Pathology Form [reload] NCT00057811

No Instruction available.

  1. StudyEvent: ANHL01P1: Institutional Pathology Form [reload]
    1. No Instruction available.
Header
Pathology evaluation
Time sample obtained (One must be chosen)
Method for obtaining tissue samples (Required field)
Source of tissue samples (Required field)
Pathologic diagnosis (Required field)
Immunophenotype (One must be chosen)
Results From Fresh Or Frozen Tissue
Antigen Type
Results from paraffin embedded tissue (One must be chosen)
TDT Method (One must be chosen)
Results From Paraffin Embedded Tissue
SLIDE/TISSUE SUBMISSION: For Central Review? (One must be chosen)
Is any frozen tissue available? (One must be chosen)
Fixative used (BIOPSY TISSUE PROCESSING DETAILS)
Number of hours in fixative before processing
Is there evidence of clonality by gene rearrangement? (Required field)
Ccrr Module For Anhl01p1: Institutional Pathology Form [reload]

Similar models